These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 3666583)

  • 1. Use of a centrifugal analyzer for a chromogenic prothrombin time, a chromogenic activated partial thromboplastin time and a kinetic fibrinogen assay in a routine hospital laboratory.
    de Metz M; van Wersch JW
    Haemostasis; 1987; 17(5):254-9. PubMed ID: 3666583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Q analyzer, a new cap-piercing fully automated coagulometer with clotting, chromogenic, and immunoturbidometric capability.
    Kitchen S; Woolley A
    Blood Coagul Fibrinolysis; 2013 Jan; 24(1):28-34. PubMed ID: 23249565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automation of routine coagulation testing using a random access centrifugal analyzer.
    Rowell JA; Elms MJ; Young J; Bunce IH
    Am J Clin Pathol; 1988 Mar; 89(3):347-52. PubMed ID: 3348169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a photometric assay for activated partial thromboplastin time and its application to the Cobas Bio centrifugal analyzer.
    Becker U; Bartl K; Lill H; Wahlefeld AW
    Thromb Res; 1985 Dec; 40(6):721-30. PubMed ID: 4089837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation and performance characteristics of the Q Hemostasis Analyzer, an automated coagulation analyzer.
    Toulon P; Fischer F; Appert-Flory A; Jambou D
    Thromb Res; 2014 May; 133(5):927-35. PubMed ID: 24650798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical evaluation of automated chromogenic tests as substitutes for conventional prothrombin time and activated partial thromboplastin time tests.
    Duncan A; Bowie EJ; Owen CA; Fass DN
    Clin Chem; 1985 Jun; 31(6):853-5. PubMed ID: 3995763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of a chromogenic prothrombin time with clotting prothrombin time in the assessment of clinical coagulation deficiencies.
    Francis CW; Malone JE; Marder VJ
    Am J Clin Pathol; 1985 Dec; 84(6):724-9. PubMed ID: 4072967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of bedside prothrombin time and activated partial thromboplastin time measurement by coagulation analyzer CoaguCheck Plus in various clinical settings.
    Ruzicka K; Kapiotis S; Quehenberger P; Handler S; Hornykewycz S; Michitsch A; Huber K; Clemens D; Susan M; Pabinger I; Eichinger S; Jilma B; Speiser W
    Thromb Res; 1997 Sep; 87(5):431-40. PubMed ID: 9306617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromogenic substrates for activated partial thromboplastin time testing: are they worth using?
    Tripodi A
    Ric Clin Lab; 1989; 19(4):355-8. PubMed ID: 2517351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the automated coagulation analyzer SYSMEX CA 6000.
    Quehenberger P; Kapiotis S; Handler S; Ruzicka K; Speiser W
    Thromb Res; 1999 Oct; 96(1):65-71. PubMed ID: 10554086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ChromoTimeSystem--a new generation of coagulation analyses.
    Kolde HJ
    Behring Inst Mitt; 1985 Dec; (78):176-87. PubMed ID: 3833242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the analytical performance of five new coagulation assays for the measurement of prothrombin time and activated thromboplastin time.
    Kitchen S; Geisen U; Kappelmayer J; Quehenberger P; Drieß J; Lowe A; Jones R; Boehm JG; Miles G; Rozsnyai G
    Int J Lab Hematol; 2018 Dec; 40(6):645-654. PubMed ID: 30033570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation and performance characteristics of the automated coagulation analyzer ACL TOP.
    Appert-Flory A; Fischer F; Jambou D; Toulon P
    Thromb Res; 2007; 120(5):733-43. PubMed ID: 17275069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Edoxaban: Impact on routine and specific coagulation assays. A practical laboratory guide.
    Douxfils J; Chatelain B; Chatelain C; Dogné JM; Mullier F
    Thromb Haemost; 2016 Jan; 115(2):368-81. PubMed ID: 26510969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the automated coagulation analyzer Sysmex CA-7000.
    Fischer F; Appert-Flory A; Jambou D; Toulon P
    Thromb Res; 2006; 117(6):721-9. PubMed ID: 16098565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of clotting screens.
    Thorell SE; Nash MJ; Thachil J
    Int J Lab Hematol; 2015 Feb; 37(1):8-13. PubMed ID: 24636194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of laboratory assays to measure rivaroxaban--an oral, direct factor Xa inhibitor.
    Samama MM; Martinoli JL; LeFlem L; Guinet C; Plu-Bureau G; Depasse F; Perzborn E
    Thromb Haemost; 2010 Apr; 103(4):815-25. PubMed ID: 20135059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Qualification of a select one-stage activated partial thromboplastin time-based clotting assay and two chromogenic assays for the post-administration monitoring of nonacog beta pegol.
    Tiefenbacher S; Bohra R; Amiral J; Bowyer A; Kitchen S; Lochu A; Rosén S; Ezban M
    J Thromb Haemost; 2017 Oct; 15(10):1901-1912. PubMed ID: 28772338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fully automated method for clot based coagulation panels using an MCA Multistat Centrifugal Analyzer.
    Hoak DR; Mammen EF; Banerjee SK; Kaldor G
    Thromb Res; 1985 Aug; 39(4):485-99. PubMed ID: 4049327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring FVIII activity of glycopegylated recombinant factor VIII, N8-GP, with commercially available one-stage clotting and chromogenic assay kits: a two-centre study.
    Hillarp A; Bowyer A; Ezban M; Persson P; Kitchen S
    Haemophilia; 2017 May; 23(3):458-465. PubMed ID: 28198071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.